StimRouter Neuromodulation System
Stimulator, Peripheral Nerve, Implanted (Pain Relief). 510(k) K211965, from Bioness, Inc. (Valencia, CA). Product code GZF, class 2.
As of Nov 22, 2026, K211965 is an FDA 510(k) held by Bioness, Inc., substantially equivalent on Feb 23, 2022 after 244 days, with no recalls tied to it in FDA's recall database.
- Review time: 244 days
- Recalls: 0
- Cited as a predicate by: 2 devices
The StimRouter Neuromodulation System is indicated for pain management in adults who have severe intractable chronic pain of peripheral nerve origin, as an adjunct to other modes of therapy (e.g., medications). The StimRouter is not intended to treat pain in the craniofacial region.
- StimRouter Neuromodulation SystemK200482 · Bioness, Inc. · Mar 27, 2020
- Nerve Stimulator, Digital PeripheralK791047 · C.R. Bard, Inc. · Jun 13, 1979
- StimTrial Neuromodulation SystemK243782 · Bioventus, LLC · Jul 16, 2025
- TalisMann Neuromodulation SystemK243678 · Bioventus, LLC · Jul 3, 2025
- StimTrial Neuromodulation SystemK253877 · Bioventus, LLC · Aug 26, 2026
- StimTrial Neuromodulation SystemK243782 · Bioventus, LLC · Jul 16, 2025
- TalisMann Neuromodulation SystemK243678 · Bioventus, LLC · Jul 3, 2025
- Nalu Neurostimulation System for Peripheral Nerve StimulationK232415 · Boston Scientific Neuromodulation · Aug 21, 2024
- Freedom Peripheral Nerve Stimulator (PNS) SystemK233162 · Curonix · Jun 20, 2024
- Neuspera Nuity SystemK221303 · Neuspera Medical, Inc. · Apr 11, 2023
- Neuspera Neurostimulation System (NNS)K202781 · Neuspera Medical, Inc. · Aug 27, 2021
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jun 24, 2021
- Review panel
- Neurology
- Regulation
- 21 CFR 882.5870
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files